Format

Send to

Choose Destination
BMC Med. 2014 Oct 22;12:200. doi: 10.1186/s12916-014-0200-8.

Remembering the forgotten non-communicable diseases.

Lopez AD1, Williams TN2,3, Levin A4, Tonelli M5, Singh JA6,7,8, Burney PG9, Rehm J10,11,12,13,14, Volkow ND15, Koob G16, Ferri CP17,18.

Author information

1
School of Population and Global Health, The University of Melbourne, Building 379, 207 Bouverie St, Carlton, Melbourne, VIC, 3053, Australia. alan.lopez@unimelb.edu.au.
2
Department of Medicine, Imperial College, St Mary's Hospital, London, W21NY, UK. tom.n.williams@gmail.com.
3
KEMRI/Wellcome Trust Research Programme, PO Box 230, Kilifi, Kenya. tom.n.williams@gmail.com.
4
University of British Columbia, St Paul's Hospital, 1081 Burrard Street Rm 6010 A, Vancouver, BC, V6Z1Y8, Canada. ALevin@providencehealth.bc.ca.
5
, 7th Floor, TRW Building, 3280 Hospital Drive NW, Calgary, Alberta, T2N 4Z6, Canada. mtonelli@ualberta.ca.
6
Medicine Service and Center for Surgical Medical Acute care Research and Transitions, VA Medical Center, 510, 20th street South, Birmingham, AL, FOT 805B, USA. jassingh@uab.edu.
7
Department of Medicine at School of Medicine, and Division of Epidemiology at School of Public Health, University of Alabama, 1720 Second Ave. South, Birmingham, AL, 35294-0022, USA. jassingh@uab.edu.
8
Department of Orthopedic Surgery, Mayo Clinic College of Medicine, 200 1st St SW, Rochester, MN, 55905, USA. jassingh@uab.edu.
9
National Heart and Lung Institute, Imperial College, London, UK. p.burney@imperial.ac.uk.
10
Centre for Addiction and Mental Health, Toronto, Canada. jtrehm@gmail.com.
11
Clinical Psychology and Psychotherapy, Technical Universität Dresden, Dresden, Germany. jtrehm@gmail.com.
12
Addiction Policy, Dalla Lana School of Public Health, University of Toronto (UofT), Toronto, Canada. jtrehm@gmail.com.
13
Department of Psychiatry, Faculty of Medicine, UofT, Toronto, Canada. jtrehm@gmail.com.
14
Institute of Medical Science, UofT, Toronto, Canada. jtrehm@gmail.com.
15
National Institute on Drug Abuse, National Institutes of Health, Rockville, MD, USA. nvolkow@nida.nih.gov.
16
National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, 20892-9304, USA. george.koob@nih.gov.
17
Institute of Education and Health Sciences, Hospital Alemao Oswaldo Cruz, Rua João Julião, 245 - Bloco D CEP 01323-903, São Paulo, SP, Brazil. ferricleusa@gmail.com.
18
Department of Psychobiology, Escola Paulista de Medicina, Universidade Federal de São Paulo, Rua Botucatu, 862- 1o andar, São Paulo, CEP, 04023-062, Brazil. ferricleusa@gmail.com.

Abstract

The forthcoming post-Millennium Development Goals era will bring about new challenges in global health. Low- and middle-income countries will have to contend with a dual burden of infectious and non-communicable diseases (NCDs). Some of these NCDs, such as neoplasms, COPD, cardiovascular diseases and diabetes, cause much health loss worldwide and are already widely recognised as doing so. However, 55% of the global NCD burden arises from other NCDs, which tend to be ignored in terms of premature mortality and quality of life reduction. Here, experts in some of these 'forgotten NCDs' review the clinical impact of these diseases along with the consequences of their ignoring their medical importance, and discuss ways in which they can be given higher global health priority in order to decrease the growing burden of disease and disability.

PMID:
25604462
PMCID:
PMC4207624
DOI:
10.1186/s12916-014-0200-8
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center